2025 second_quarter Filing
Q2Income
$60K
Filed
July 21, 2025
Lobbying Activities
Health IssuesView all
General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; drug importation; and drug shortages. Drug pricing proposals. The 340B program. Pharmacy benefit manager reform proposals. H.R. 1; issues related to biopharmaceutical drug pricing, particularly related to MFN.
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Taxation/Internal Revenue CodeView all
Tax issues affecting the pharmaceutical industry including international tax; including tax issues under consideration for reconciliation legislation and H.R. 1, One Big Beautiful Bill Act". Vaccine excise tax issues and VICP.
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (9)
SUSAN HIRSCHMANN
ms MELINDA M MAXFIELD
mr MATTHEW B HOEKSTRA
CHRISTOPHER E. WILCOX
LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings